Klippel-Trenaunay Syndrome and Cellulitis: Orthopaedic Considerations and Risk Factors – A Case Report
Journal of the American Osteopathic Academy of Orthopedics · 2025
DOI: 10.70709/1njnwlyldh ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the American Osteopathic Academy of Orthopedics, 2025. Verfasst von Gabrielle Aluisio und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Case: A 41-year-old female with Klippel-Trenaunay Syndrome (KTS) presented with worsening left lower extremity cellulitis and non-healing ulcers. Her medical history included epilepsy and hemiplegic migraines. Physical examination revealed ulcerations, erythema, and vascular malformations. Laboratory tests indicated leukocytosis and systemic inflammation. MRI confirmed vascular malformations and infection. The patient was treated with antibiotics and wound care, leading to improvement in her condition. Conclusion: This case highlights the increased risk of cellulitis in patients with KTS due to vascular malformations and chronic venous insufficiency. It also underscores the importance of early intervention and a multidisciplinary approach to prevent recurrent cellulitis and related complications, such as osteomyelitis.
Zitieren
APA
Aluisio, G., & Tjiattas-Saleski, L. (2025). Klippel-Trenaunay Syndrome and Cellulitis: Orthopaedic Considerations and Risk Factors – A Case Report. Journal of the American Osteopathic Academy of Orthopedics. https://doi.org/10.70709/1njnwlyldh
Vancouver
Aluisio G, Tjiattas-Saleski L. Klippel-Trenaunay Syndrome and Cellulitis: Orthopaedic Considerations and Risk Factors – A Case Report. Journal of the American Osteopathic Academy of Orthopedics. 2025. doi:10.70709/1njnwlyldh
BibTeX
@article{Aluisio2025,
author = {Aluisio, Gabrielle and Tjiattas-Saleski, Lindsey},
title = {Klippel-Trenaunay Syndrome and Cellulitis: Orthopaedic Considerations and Risk Factors – A Case Report},
journal = {Journal of the American Osteopathic Academy of Orthopedics},
year = {2025},
doi = {10.70709/1njnwlyldh}
}
EUVIMED